DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (62)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 62   Next >>

Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Anaemia, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 micrograms per 0.5 ml injection qw
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-08-03

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    End date: 2012-08-03

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27

Other drugs received by patient: Oxycodone HCL; Clonazepam; Nicotine; Celexa; Neuroxin (Cyanocobalamin (+) Pyridoxine Hydrochloride (+) Thiamine HYD



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: daily dosage unknown
    Indication: Hepatitis C
    Start date: 2010-01-01

Rebetol
    Dosage: daily dosage unknown
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-01



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-22

Patient:

Reactions: Pulmonary Embolism, Suicide Attempt, Depression, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

PEG-Intron
    Dosage: 120 micrograms, qw
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-11
    End date: 2011-01-06

Peginterferon Alfa-2B
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Placebo
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-11
    End date: 2011-01-07

Ribavirin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Other drugs received by patient: Norvir; Zolpidem Tatrate; Reyataz; Xanax; Escitalopram Oxalate; Epivir; Imodium; Invirase



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Enanthema, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-29
    End date: 2012-05-09

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-29

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-03-29
    End date: 2012-05-29

PEG-Intron
    Dosage: 1.5 microgram per kilogram, per week
    Start date: 2012-03-29
    End date: 2012-05-28

PEG-Intron
    Dosage: unk

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-29
    End date: 2012-04-18

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-02
    End date: 2012-05-16

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-19
    End date: 2012-05-01

Rebetol
    Dosage: unk mg, once
    Administration route: Oral
    Start date: 2012-05-17
    End date: 2012-05-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-05-28

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Start date: 2012-03-29
    End date: 2012-05-09

Other drugs received by patient: Myser (Difluprednate); Levocarnitine Hydrochloride; Myser (Cycloserine); Ferrous Sulfate TAB; Locoid; L Cartin; Ferrous Sulfate TAB; Locoid; Allopurinol; L Cartin; Myser (Difluprednate); Allegra; Talion (Bepotastine Besylate); Talion (Bepotastine Besylate); Allopurinol



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15

Patient:

Reactions: Major Depression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-05-30



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Anaemia, Suicidal Ideation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-08-03

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    End date: 2012-08-03

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-03

Patient:

Reactions: Subarachnoid Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Start date: 2012-01-06
    End date: 2012-04-19

PEG-Intron
    Dosage: 80 ?g, qw
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06
    End date: 2012-04-19

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06
    End date: 2012-04-25

Other drugs received by patient: Loxoprofen; Allegra; Allegra; Teprenone; Teprenone



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a physician from Austria on 2012-07-30

Patient:

Reactions: Agranulocytosis, Anaemia, Platelet Count Decreased, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram, unk
    Indication: Hepatitis C
    Start date: 2012-03-21
    End date: 2012-06-10

Rebetol
    Dosage: unk
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-21
    End date: 2012-06-10



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-29

Patient:

Reactions: Death

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis



Possible PEG-Intron side effects in

Reported by a physician from Germany on 2012-07-20

Patient:

Reactions: Vomiting, Renal Failure, Sepsis, Urinary Tract Infection, Hepatic Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: 1600 mg
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

PEG-Intron
    Dosage: 180 micg, qw
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

Victrelis
    Dosage: 3 x 800
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-19

Other drugs received by patient: Citalopram Hydrobromide; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Ramipril



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-07-12

Patient:

Reactions: Anaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1,5 ug/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-30
    End date: 2012-06-15

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-04

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-05-03

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-30
    End date: 2012-04-26

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    End date: 2012-06-15

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-30
    End date: 2012-06-15



Possible PEG-Intron side effects in

Reported by a physician from Germany on 2012-07-11

Patient:

Reactions: Vomiting, Renal Failure, Urinary Tract Infection, Hepatic Failure

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Copegus
    Dosage: 1600 mg
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

PEG-Intron
    Dosage: 180 micg, qw
    Indication: Hepatitis C
    Start date: 2012-01-05
    End date: 2012-06-19

Victrelis
    Dosage: 3 x 800
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-19

Other drugs received by patient: Ramipril; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Citalopram Hydrobromide



Possible PEG-Intron side effects in 37 year old female

Reported by a physician from Japan on 2012-07-05

Patient: 37 year old female, weighing 46.0 kg (101.2 pounds)

Reactions: Ruptured Cerebral Aneurysm, Subarachnoid Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 mcg, qw, sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06
    End date: 2012-04-19

Rebetol
    Dosage: 600 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-06
    End date: 2012-04-25

Other drugs received by patient: Allegra; Loxoprofen; Teprenone



Possible PEG-Intron side effects in 37 year old female

Reported by a physician from Brazil on 2012-07-03

Patient: 37 year old female, weighing 66.3 kg (145.9 pounds)

Reactions: Anaemia, Pancytopenia, Fibromyalgia, Apparent Life Threatening Event, Depression, Acute Respiratory Failure, Septic Shock, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-05-27

Ribavirin
    Dosage: 500 mg;q12h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-05-27

Victrelis
    Dosage: 800 mcg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-05-27

Other drugs received by patient: Clonazepam; Sertraline Hydrochloride



Possible PEG-Intron side effects in 37 year old female

Reported by a physician from Germany on 2012-06-26

Patient: 37 year old female

Reactions: Renal Failure, Hepatic Failure

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-18

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-18

Victrelis
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-18

Other drugs received by patient: Ramipril; Mirtazapine; Citalopram Hydrobromide; Metoclopramide; Lercanidipine; Haloperidol



Possible PEG-Intron side effects in 51 year old male

Reported by a physician from Austria on 2012-06-19

Patient: 51 year old male, weighing 90.0 kg (198.0 pounds)

Reactions: Syncope, Brain Abscess, Epilepsy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 mcg;qw;sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-09

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-09

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-06-15



Possible PEG-Intron side effects in female

Reported by a physician from United States on 2012-06-12

Patient: female

Reactions: Overdose, Suicide Attempt

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Indication: Product Used FOR Unknown Indication

PEG-Intron
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Indication: Product Used FOR Unknown Indication



Possible PEG-Intron side effects in female

Reported by a pharmacist from United States on 2012-06-01

Patient: female, weighing 108.9 kg (239.5 pounds)

Reactions: Suicidal Ideation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150mcg once weekly sq
    Indication: Hepatitis C
    Start date: 2012-03-14
    End date: 2012-05-31

Ribavirin
    Dosage: 400mg bid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-14
    End date: 2012-05-31



Possible PEG-Intron side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-09

Patient: 5 year old male, weighing 32.5 kg (71.5 pounds)

Reactions: Renal Tubular Disorder, Dyskinesia, Disseminated Intravascular Coagulation, Petechiae, Hepatic Failure, Mental Status Changes, Coma, Headache, Pyrexia, Lactic Acidosis, Urine Output Increased, Generalised Oedema, Malaise, Acute Respiratory Distress Syndrome, Pulmonary Oedema, Electrolyte Imbalance, Vomiting, International Normalised Ratio Increased, Respiratory Distress, Tremor, Nephrogenic Diabetes Insipidus, Convulsion, Renal Failure, Product Packaging Issue, Mitochondrial Toxicity, Depressed Level of Consciousness, Rash Maculo-Papular, Multi-Organ Disorder, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 445 mg;once;rtl
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-07

Acetaminophen
    Dosage: 400 mg;once ; 400 mg;once
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-07

Acetaminophen
    Dosage: 400 mg;once ; 400 mg;once
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-07

PEG-Intron
    Dosage: 64 mcg;sc
    Indication: Hepatitis C
    Start date: 2010-01-07
    End date: 2010-01-07

Rebetol
    Dosage: 240 mg;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-07
    End date: 2010-01-07



Possible PEG-Intron side effects in 59 year old female

Reported by a pharmacist from United States on 2012-04-30

Patient: 59 year old female

Reactions: Nausea, Dehydration, Platelet Count Decreased, Hallucination, Delirium, Epistaxis, Diabetes Mellitus Inadequate Control

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Product Used FOR Unknown Indication

Ribasphere
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: ;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-01

Other drugs received by patient: Bupropion HCL; Seroquel; Diovan; Hydrochlorothiazide; Citalopram Hydrobromide; Novolog; Humulin R



Possible PEG-Intron side effects in male

Reported by a pharmacist from United States on 2012-04-18

Patient: male

Reactions: Back Pain, Pruritus, Nausea, DRY Skin, Discomfort, Fluid Retention

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150mcg weekly sq
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-28

Ribavirin
    Dosage: 600 mg bid oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-28



Possible PEG-Intron side effects in 64 year old male

Reported by a physician from Japan on 2012-04-09

Patient: 64 year old male, weighing 64.0 kg (140.8 pounds)

Reactions: Blood Bilirubin Increased, Hepatic Necrosis, Blood Urea Increased, Alanine Aminotransferase Increased, Hepatic Failure, Haemodialysis, Blood Uric Acid Increased, Aspartate Aminotransferase Increased, Prothrombin Time Shortened, Blood Creatinine Increased, Bilirubin Conjugated Increased, Altered State of Consciousness, Decreased Appetite, Blood Glucose Increased

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-06

Rebetol
    Dosage: 800 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-11

Telavic (Telaprevir) (Investigational Drug)
    Dosage: 2250 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-11

Other drugs received by patient: Nexium; Urso 250; Magmitt; Actos; Portolac; Amaryl; Talion



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-06

Patient: 57 year old female

Reactions: Pulmonary Necrosis, Metabolic Acidosis, Continuous Haemodiafiltration, Hepatic Failure, Treatment Noncompliance, Lung Abscess, Ascites, Multi-Organ Failure, Renal Failure, Dialysis, Respiratory Failure, Pneumonia Staphylococcal, Skin Infection, Septic Shock, Immunosuppression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Boceprevir (Sch-503034)
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2011-01-30

Ribavirin
    Dosage: 400 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2011-07-01

Ribavirin
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



Possible PEG-Intron side effects in 44 year old female

Reported by a physician from United States on 2012-04-02

Patient: 44 year old female

Reactions: Sepsis, Hepatic Cirrhosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: ;sc
    Indication: Hepatitis C

Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: ;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012